Recombinant Protein Market Revenue and Value Chain 2018-2028

Pune, Maharashtra -- (SBWire) -- 02/19/2019 --Proteins resulting from expression of recombinant DNA (rDNA), within living cells, are known as recombinant proteins. rDNAs are DNA molecules that are formed by laboratory procedures of genetic recombination, to bring genetic material together from multiple sources. DNA sequences used for constructing recombinant DNA molecules originate from any species. If the DNA sequences do not occur in nature, they can be created through chemical synthesis of DNA, further incorporating them into recombinant molecules.

Clinical trial period for recombinant protein is shorter as compared to small molecule drugs. This further helps in enhancing the patient protection, providing pharmaceutical companies with longer exclusive sales time. These factors have fuelled the development as well as demand for recombinant protein. Recombinant proteins are targeted at major diseases including endocrine diseases, cardiovascular diseases, cancer, and viral diseases. Moreover, the global market for recombinant proteins has larger extension space. Few approval drugs are available in the recombinant protein market, with no substitute products in therapeutic areas. However, owing to higher financial barriers, and technical barriers, recombinant proteins are subject to high costs. Replicating recombinant proteins is a more difficult task than that of small molecule chemicals. Fact.MR's report projects the global market for recombinant protein to expand at an average CAGR during the forecast period (2017 to 2022). The market is estimated to account for nearly US$ 460 Mn revenues by 2022-end.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=186

North America to Remain Dominant in the Market

North America will continue to retain its dominance in the global recombinant protein market, with sales projected to reach nearly US$ 150 Mn by 2022-end. Europe is estimated to be the second most lucrative market for recombinant protein throughout the forecast period. The market in Middle East & Africa (MEA) is anticipated to witness a sluggish expansion through 2022.

Recombinant proteins factoring molecular growth will remain the most lucrative product in the market, followed by checkpoint regulators. In addition, sales of growth factors, and cytokines are poised to exhibit similar CAGRs through 2022. However, sales of chemokines are estimated to register the fastest expansion through 2022. Demand for enzymes & inhibitors will continue to be sluggish throughout the forecast period.

Although academic & research institutes are expected to remain the largest end-users of recombinant proteins in terms of revenues, sales in biopharmaceutical companies will register the highest CAGR compared to all the other end-user segments through 2022. Revenues from sales of recombinant proteins in academic & research institutes will account for over one-third market share during 2017 to 2022.

Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=186

Competition Tracking

Leading players in the global recombinant protein market include Abcam plc, A.M.S. Biotechnology (Europe) Limited, Bio-Rad Laboratories, Inc., BPS Bioscience Inc., PerkinElmer, Inc., Crown Bioscience, Inc., GenScript Corporation, Merck Millipore Limited, Sigma Aldrich, and Thermo Fisher Scientific, Inc.

Detailed TOC of Global Recombinant Proteins Market by Manufacturers, Regions, Type and Application, Forecast to 2022

1. Global Recombinant Proteins Market - Executive Summary

2. Global Recombinant Proteins Market Overview
2.1. Introduction
2.1.1. Global Recombinant Proteins Market Taxonomy
2.1.2. Global Recombinant Proteins Market Definition
2.2. Global Recombinant Proteins Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Recombinant Proteins Market Y-o-Y Growth
2.3. Global Recombinant Proteins Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=186

3. Global Recombinant Proteins Market Analysis and Forecast By Product Type
3.1. Global Recombinant Proteins Market Size and Forecast By Product Type, 2012-2022
3.1.1. Immune Checkpoint Regulators Recombinant Proteins Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Chemokines Recombinant Proteins Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
3.1.3. Growth Factors Recombinant Proteins Market Size and Forecast, 2012-2022
3.1.3.1. Revenue (US$ Mn) Comparison, By Region
3.1.3.2. Market Share Comparison, By Region
3.1.3.3. Y-o-Y growth Comparison, By Region
3.1.4. Cytokines Recombinant Proteins Market Size and Forecast, 2012-2022
3.1.4.1. Revenue (US$ Mn) Comparison, By Region
3.1.4.2. Market Share Comparison, By Region
3.1.4.3. Y-o-Y growth Comparison, By Region
3.1.5. Colony Stimulating Factors Recombinant Proteins Market Size and Forecast, 2012-2022
3.1.5.1. Revenue (US$ Mn) Comparison, By Region
3.1.5.2. Market Share Comparison, By Region
3.1.5.3. Y-o-Y growth Comparison, By Region
3.1.6. Hormones Recombinant Proteins Market Size and Forecast, 2012-2022
3.1.6.1. Revenue (US$ Mn) Comparison, By Region
3.1.6.2. Market Share Comparison, By Region
3.1.6.3. Y-o-Y growth Comparison, By Region
3.1.7. Enzymes & Inhibitors Recombinant Proteins Market Size and Forecast, 2012-2022
3.1.7.1. Revenue (US$ Mn) Comparison, By Region
3.1.7.2. Market Share Comparison, By Region
3.1.7.3. Y-o-Y growth Comparison, By Region
3.1.8. Other Recombinant Proteins Market Size and Forecast, 2012-2022
3.1.8.1. Revenue (US$ Mn) Comparison, By Region
3.1.8.2. Market Share Comparison, By Region
3.1.8.3. Y-o-Y growth Comparison, By Region

Access This Report @ https://www.factmr.com/checkout/186/S

4. Global Recombinant Proteins Market Analysis and Forecast By End User
4.1. Global Recombinant Proteins Market Size and Forecast By End User, 2012-2022
4.1.1. Biopharmaceutical Companies Recombinant Proteins Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Contract Research Organizations (CROs) Recombinant Proteins Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Academic & Research Institutes Recombinant Proteins Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Forensic Science Laboratories Recombinant Proteins Market Size and Forecast, 2012-2022
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.1.5. Food & Beverage Companies Recombinant Proteins Market Size and Forecast, 2012-2022
4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region
4.1.6. Diagnostic Centers Recombinant Proteins Market Size and Forecast, 2012-2022
4.1.6.1. Revenue (US$ Mn) Comparison, By Region
4.1.6.2. Market Share Comparison, By Region
4.1.6.3. Y-o-Y growth Comparison, By Region
4.1.7. Others Recombinant Proteins Market Size and Forecast, 2012-2022
4.1.7.1. Revenue (US$ Mn) Comparison, By Region
4.1.7.2. Market Share Comparison, By Region
4.1.7.3. Y-o-Y growth Comparison, By Region

5. Global Recombinant Proteins Market Analysis and Forecast By Application
5.1. Global Recombinant Proteins Market Size and Forecast By Application, 2012-2022
5.1.1. Drug Discovery & Development Recombinant Proteins Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Region
5.1.1.2. Market Share Comparison, By Region
5.1.1.3. Y-o-Y growth Comparison, By Region
5.1.2. Basic Research Recombinant Proteins Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Region
5.1.2.2. Market Share Comparison, By Region
5.1.2.3. Y-o-Y growth Comparison, By Region
5.1.3. Toxicity Screening Recombinant Proteins Market Size and Forecast, 2012-2022
5.1.3.1. Revenue (US$ Mn) Comparison, By Region
5.1.3.2. Market Share Comparison, By Region
5.1.3.3. Y-o-Y growth Comparison, By Region
5.1.4. Biopharmaceutical Production Recombinant Proteins Market Size and Forecast, 2012-2022
5.1.4.1. Revenue (US$ Mn) Comparison, By Region
5.1.4.2. Market Share Comparison, By Region
5.1.4.3. Y-o-Y growth Comparison, By Region
5.1.5. Drug Screening Recombinant Proteins Market Size and Forecast, 2012-2022
5.1.5.1. Revenue (US$ Mn) Comparison, By Region
5.1.5.2. Market Share Comparison, By Region
5.1.5.3. Y-o-Y growth Comparison, By Region
5.1.6. Tissue Engineering Recombinant Proteins Market Size and Forecast, 2012-2022
5.1.6.1. Revenue (US$ Mn) Comparison, By Region
5.1.6.2. Market Share Comparison, By Region
5.1.6.3. Y-o-Y growth Comparison, By Region
5.1.7. Forensic Testing Recombinant Proteins Market Size and Forecast, 2012-2022
5.1.7.1. Revenue (US$ Mn) Comparison, By Region
5.1.7.2. Market Share Comparison, By Region
5.1.7.3. Y-o-Y growth Comparison, By Region

6. Global Recombinant Proteins Market Analysis and Forecast By Region
6.1. Global Recombinant Proteins Market Size and Forecast, 2012-2022
6.1.1. North America Recombinant Proteins Market Size and Forecast, 2012-2022
6.1.1.1. Revenue (US$ Mn) Comparison, By Product Type
6.1.1.2. Revenue (US$ Mn) Comparison, By End User
6.1.1.3. Revenue (US$ Mn) Comparison, By Application
6.1.2. Latin America Recombinant Proteins Market Size and Forecast, 2012-2022
6.1.2.1. Revenue (US$ Mn) Comparison, By Product Type
6.1.2.2. Revenue (US$ Mn) Comparison, By End User
6.1.2.3. Revenue (US$ Mn) Comparison, By Application
6.1.3. Europe Recombinant Proteins Market Size and Forecast, 2012-2022
6.1.3.1. Revenue (US$ Mn) Comparison, By Product Type
6.1.3.2. Revenue (US$ Mn) Comparison, By End User
6.1.3.3. Revenue (US$ Mn) Comparison, By Application
6.1.4. Japan Recombinant Proteins Market Size and Forecast, 2012-2022
6.1.4.1. Revenue (US$ Mn) Comparison, By Product Type
6.1.4.2. Revenue (US$ Mn) Comparison, By End User
6.1.4.3. Revenue (US$ Mn) Comparison, By Application
6.1.5. APEJ Recombinant Proteins Market Size and Forecast, 2012-2022
6.1.5.1. Revenue (US$ Mn) Comparison, By Product Type
6.1.5.2. Revenue (US$ Mn) Comparison, By End User
6.1.5.3. Revenue (US$ Mn) Comparison, By Application
6.1.6. MEA Recombinant Proteins Market Size and Forecast, 2012-2022
6.1.6.1. Revenue (US$ Mn) Comparison, By Product Type
6.1.6.2. Revenue (US$ Mn) Comparison, By End User
6.1.6.3. Revenue (US$ Mn) Comparison, By Application

And Continue...

List of Figures, Tables and Charts Available in Global Recombinant Proteins Market 2017 by Manufacturers, Regions, Type and Application, Forecast to 2022

TABLE 1 Global Recombinant Proteins Market Value (US$ Mn), 2012-2016
TABLE 2 Global Recombinant Proteins Market Value (US$ Mn), 2017-2022
TABLE 3 Global Recombinant Proteins Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Immune Checkpoint Regulators Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Immune Checkpoint Regulators Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Immune Checkpoint Regulators Segment Market Share, By Region 2012-2016
TABLE 7 Global Immune Checkpoint Regulators Segment Market Share, By Region 2017-2022
TABLE 8 Global Immune Checkpoint Regulators Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Chemokines Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Chemokines Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Chemokines Segment Market Share, By Region 2012-2016
TABLE 12 Global Chemokines Segment Market Share, By Region 2017-2022
TABLE 13 Global Chemokines Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Growth Factors Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Growth Factors Segment Value (US$ Mn), By Region 2017-2022

And Continue...

FIG. 1 Global Recombinant Proteins Market Value (US$ Mn), 2012-2016
FIG. 2 Global Recombinant Proteins Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Recombinant Proteins Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Immune Checkpoint Regulators Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Immune Checkpoint Regulators Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Immune Checkpoint Regulators Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Chemokines Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Chemokines Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Chemokines Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Growth Factors Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Growth Factors Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Growth Factors Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Cytokines Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Cytokines Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Cytokines Segment Y-o-Y Growth Rate, By Region, 2015-2022

And Continue...

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Web: https://www.factmr.com/ 
Read Industry News at - https://theswisstimes.com